EHR-based Thromboembolism Risk Tools Boosts Prophylaxis

A clinical decision-support tool designed to identify hospitalized patients in need of VTE prophylaxis cut the rate of thromboembolism at 30 days in the randomized IMPROVE-DD VTE trial.

Related Keywords

Boston ,Massachusetts ,United States ,New York ,Boston University ,Chicago ,Illinois ,American ,Alexc Spyropoulos ,Elainem Hylek ,Gregory Piazza ,American Heart Association ,Northwell Health ,Agency For Healthcare Research ,More Detail ,Healthcare Research ,Thromboembolism ,Healthcare Technology ,Ealth Care Technology ,Hospitals ,Prophylaxis ,Electronic Medical Record Emr ,Electronic Medical Record ,Omputerized Medical Records Systems ,Mr ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,Atrial Fibrillation ,F Atrial Fibrillation ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc4 ,